PetMed Express, Inc. (NASDAQ:PETS) Shares Sold by Royce & Associates LP

Royce & Associates LP lowered its position in shares of PetMed Express, Inc. (NASDAQ:PETS) by 35.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,407 shares of the company’s stock after selling 7,250 shares during the quarter. Royce & Associates LP owned 0.07% of PetMed Express worth $49,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Bleakley Financial Group LLC purchased a new position in shares of PetMed Express in the third quarter worth approximately $279,000. Point72 DIFC Ltd purchased a new stake in PetMed Express in the 2nd quarter worth about $34,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in PetMed Express during the 2nd quarter worth about $135,000. Squarepoint Ops LLC acquired a new position in shares of PetMed Express in the 2nd quarter valued at about $273,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in shares of PetMed Express in the second quarter worth approximately $797,000. 73.33% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other PetMed Express news, major shareholder Nina Capital Holdings Inc. acquired 12,500 shares of PetMed Express stock in a transaction dated Monday, September 9th. The stock was bought at an average cost of $3.34 per share, with a total value of $41,750.00. Following the acquisition, the insider now owns 2,078,000 shares of the company’s stock, valued at approximately $6,940,520. The trade was a 0.61 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.10% of the stock is owned by company insiders.

Analyst Ratings Changes

PETS has been the topic of a number of research reports. Lake Street Capital reaffirmed a “hold” rating and issued a $3.50 price target (down from $7.00) on shares of PetMed Express in a research note on Wednesday, August 7th. StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

PetMed Express Price Performance

PETS stock opened at $4.58 on Thursday. The company has a 50-day moving average of $4.09 and a two-hundred day moving average of $3.94. The stock has a market capitalization of $94.64 million, a price-to-earnings ratio of -76.33 and a beta of 0.68. PetMed Express, Inc. has a 52-week low of $2.90 and a 52-week high of $7.90.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million for the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. Equities analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.